News

Youth with neurodevelopmental disorders face significant suicide risks.

Boehringer Ingelheim and Click Therapeutics achieve breakthrough results in treating negative schizophrenia symptoms with investigational prescription digital therapeutic CT-155.

Serum drug levels provide crucial insights for optimizing psychiatric treatment, enhancing patient outcomes in cases of schizophrenia and OCD.

What are the parallels between train travel and psychiatric care?

We want to emphasize the importance of diversity in mental health care, offering resources to enhance culturally informed practices for all clinicians.

Adial Pharmaceuticals just wrapped a successful end of phase 2 meeting with the FDA and will now advance its innovative treatment for alcohol use disorder, AD04.

Extreme heat poses serious health risks, especially for vulnerable populations. Learn essential tips to help patients stay safe during heat waves and protect their well-being.

Benzodiazepines spark ongoing debate, balancing effective anxiety relief with addiction risks, as cultural attitudes shape their use and perception.

Explore the intersection of art and war, revealing how artists can uniquely interpret conflict and enhance mental health care through creative expression.

Exploring the impact of fermented foods like sauerkraut on social anxiety, revealing surprising insights and practical solutions for mental health.

Emergency departments face unique challenges with malingering patients, requiring compassionate communication and understanding to navigate complex interactions effectively.

Learn more about effective strategies for managing obesity and metabolic dysfunction in schizophrenia, focusing on dietary interventions and pharmacological treatments.

The themes of forgiveness and redemption in Shakespeare and contemporary plays highlight their impact on mental health and societal healing.

Our August theme: the complexities of ADHD, including assessment, treatment options, and comorbidities. Share your insights!

Explore the psychological depths of Macbeth's ambition and its destructive consequences, reflecting on leadership challenges in today's society.

These 2 memoirs delve into mental health, revealing the complexities of personal struggles and the pursuit of self-acceptance.

Biogen's zuranolone gains positive opinion for treating postpartum depression, promising rapid symptom relief and potential EU approval by 2025.

Check out the pipeline updates from July!

Anavex Life Sciences reveals significant cognitive and functional improvements in early Alzheimer disease patients using blarcamesine, highlighting its potential as a long-term treatment.

Explore the parallels between Shakespeare's "As You Like It" and today's societal challenges, highlighting love, resilience, and the role of psychiatry.

The FDA has cleared the IND application for MIRA Pharmaceuticals' Ketamir-2, a promising oral treatment for neuropathic pain, which has shown superior efficacy and safety in preclinical studies.

Acumen Pharmaceuticals reveals a breakthrough blood assay that enhances Alzheimer’s trial efficiency and highlights sabirnetug's selectivity for toxic amyloid beta oligomers.

Research reveals significant risks of neonatal complications linked to in utero valproic acid exposure, emphasizing the need for careful management during pregnancy.

Cognition Therapeutics reveals promising phase 2 results for zervimesine in treating dementia with Lewy bodies and Alzheimer disease at AAIC 2025.

Discover the transformative power of pausing and resetting through meditation and breathing techniques for enhanced well-being and resilience.

Cingulate secures a $4.3 million FDA fee waiver for its innovative ADHD treatment, CTx-1301, enhancing patient care with extended efficacy.

Mass shootings in the US spark debate on mental health and gun laws, contrasting with Canada's approach to violence prevention and gun control.

Roche unveils promising Alzheimer disease treatments and diagnostic tools, including trontinemab and the Elecsys pTau217 blood test, at the AAIC conference.

Valproic acid poses significant risks during pregnancy, including congenital malformations and neurodevelopmental disorders, necessitating careful treatment planning.